TransVax (Network Immunology)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTransVax (Network Immunology)

Drug Alias Nameanti-anti-donor IgGs (Network Immunology)anti-anti-donor immunoglobulins (Network Immunology)anti-anti-MHC antibodies (Network Immunology)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionImmunoglobulin agonists

TargetsImmunoglobulin

Therapy Area/IndicationsRejection of organ transplantation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNetwork Immunology Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNetwork Immunology Inc

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A